BELGIUM-HEALTH-VIRUS-VACCINE-GSK

An employee is at work on the vaccine packing line of the factory of British pharmaceutical company GlaxoSmithKline (GSK) in Wavre on February 8, 2021 where the Covid-19 CureVac vaccine will be produced. British pharmaceutical group GlaxoSmithKline (GSK) and German biotech firm CureVac announced plans to jointly develop a coronavirus vaccine with the potential to counter multi-variants of Covid-19. (Photo by Kenzo TRIBOUILLARD / AFP) (Photo by KENZO TRIBOUILLARD/AFP via Getty Images)
An employee is at work on the vaccine packing line of the factory of British pharmaceutical company GlaxoSmithKline (GSK) in Wavre on February 8, 2021 where the Covid-19 CureVac vaccine will be produced. British pharmaceutical group GlaxoSmithKline (GSK) and German biotech firm CureVac announced plans to jointly develop a coronavirus vaccine with the potential to counter multi-variants of Covid-19. (Photo by Kenzo TRIBOUILLARD / AFP) (Photo by KENZO TRIBOUILLARD/AFP via Getty Images)
BELGIUM-HEALTH-VIRUS-VACCINE-GSK
PURCHASE A LICENCE
How can I use this image?
£375.00
GBP

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses. Full editorial rights UK, US, Ireland, Italy, Spain, Canada (not Quebec). Restricted editorial rights elsewhere, please call local office.
Credit:
KENZO TRIBOUILLARD / Contributor
Editorial #:
1231044462
Collection:
AFP
Date created:
08 February, 2021
Upload date:
Licence type:
Rights-managed
Release info:
Not released. More information
Source:
AFP
Barcode:
AFP
Object name:
AFP_92H7H2
Max file size:
4453 x 2969 px (37.70 x 25.14 cm) - 300 dpi - 4 MB